Although the potential mechanisms through which SWI/SNF complexes inhibit or promote HCC have been described in the different subsections above, insight into the specific mechanisms underlying tumour suppression or promotion and the reasons for the differing cancer spectrum associated with each subunit is still in its infancy. This evidence concerns the gene SMARCA1 and hepatocellular carcinoma.